Table 3. Correlation analysis and multivariate linear regression analysis of baseline PWV.
baPWV |
haPWV |
|||||||
---|---|---|---|---|---|---|---|---|
Correlation coefficient | P value | Multivariate regression, adjusted R2 = 0.474 |
Correlation coefficient | P value | Multivariate regression, adjusted R2 = 0.477 |
|||
β (95% C.I) | P value | β (95% C.I) | P value | |||||
Age, years | 0.486 | <0.001 | 7.895 (2.546~13.243) | 0.004 | 0.386 | <0.001 | 3.281 (0.795~5.768) | 0.01 |
Gender | −0.04 | 0.695 | 0.097 | 0.351 | ||||
LVH | 0.24 | 0.03 | 0.26 | 0.02 | ||||
Hypertension history, years | 0.493 | <0.001 | 12.181 (3.547~20.815) | 0.023 | 0.433 | <0.001 | 3.666 (−0.325~7.658) | 0.071 |
Number of anti-hypertensive medication | 0.211 | 0.034 | 0.181 | 0.078 | ||||
Use of ACEI | 0.218 | 0.028 | 0.167 | 0.107 | ||||
Use of clonidine | 0.395 | <0.001 | 0.368 | <0.001 | ||||
Height, cm | −0.26 | 0.009 | −0.06 | 0.568 | ||||
Weight, kg | −0.15 | 0.139 | −0.08 | 0.465 | ||||
BMI | −0.015 | 0.884 | −0.065 | 0.532 | ||||
Potassium, mmol/L | 0.055 | 0.584 | −0.006 | 0.952 | ||||
Creatinine, mg/dL | 0.296 | 0.003 | 0.182 | 0.08 | ||||
Log PAC | 0.035 | 0.724 | 0.033 | 0.748 | ||||
Log PRA | 0.15 | 0.14 | 0.05 | 0.65 | ||||
Log ARR | −0.11 | 0.39 | −0 | 0.989 | ||||
SBP, mmHg | 0.473 | <0.001 | 4.942 (2.724~7.160 ) | <0.001 | 0.521 | <0.001 | 1.746 (0.429~3.064) | 0.01 |
DBP, mmHg | 0.324 | 0.001 | 0.467 | <0.001 | 2.668 (0.681~4.655) | 0.009 |
Values are mean ± SD. BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; ACEI = angiotensin converting enzyme inhibitor; LVH = left ventricular hypertrophy; Log PAC = log-transformed plasma aldosterone concentration; Log PRA = log-transformed plasma renin activity; Log ARR = log-transformed aldosterone to renin ratio.